Selective Activation of a Prodrug by Thioredoxin Reductase Providing a Strategy to Target Cancer Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective Activation of a Prodrug by Thioredoxin Reductase Providing a Strategy to Target Cancer Cells
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 57, Issue 21, Pages 6141-6145
Publisher
Wiley
Online
2018-03-27
DOI
10.1002/anie.201801058
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics
- (2018) Min Hee Lee et al. CHEMICAL SOCIETY REVIEWS
- The A to Z of modulated cell patterning by mammalian thioredoxin reductases
- (2018) Markus Dagnell et al. FREE RADICAL BIOLOGY AND MEDICINE
- Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches
- (2017) Özden Karaca et al. INORGANIC CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase
- (2017) Hui-Li Ng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tamoxifen-like metallocifens target the thioredoxin system determining mitochondrial impairment leading to apoptosis in Jurkat cells
- (2017) Valeria Scalcon et al. Metallomics
- Targeting the Thioredoxin System for Cancer Therapy
- (2017) Junmin Zhang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers
- (2017) Brigitte Renoux et al. Chemical Science
- Highly Selective Fluorescent Probe for Imaging H2Se in Living Cells and in Vivo Based on the Disulfide Bond
- (2016) Fanpeng Kong et al. ANALYTICAL CHEMISTRY
- Targeting Cancer with PCPA-Drug Conjugates: LSD1 Inhibition-Triggered Release of 4-Hydroxytamoxifen
- (2016) Yosuke Ota et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation
- (2016) Nick Cox et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Inhibition of thioredoxin reductase by alantolactone prompts oxidative stress-mediated apoptosis of HeLa cells
- (2016) Junmin Zhang et al. BIOCHEMICAL PHARMACOLOGY
- A small molecule probe reveals declined mitochondrial thioredoxin reductase activity in a Parkinson's disease model
- (2016) Yaping Liu et al. CHEMICAL COMMUNICATIONS
- A fast response and red emission probe for mammalian thioredoxin reductase
- (2016) Huilong Ma et al. CHEMICAL COMMUNICATIONS
- Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance
- (2016) Rotem Engelman et al. FREE RADICAL BIOLOGY AND MEDICINE
- Designing piperlongumine-directed anticancer agents by an electrophilicity-based prooxidant strategy: A mechanistic investigation
- (2016) Wen-Jing Yan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells
- (2016) Dongzhu Duan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anticancer and Antiangiogenic Iron(II) Complexes That Target Thioredoxin Reductase to Trigger Cancer Cell Apoptosis
- (2016) Lina Xie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Liposomal Texaphyrin Theranostics for Metastatic Liver Cancer
- (2016) Min Hee Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody–drug conjugates
- (2016) Leanna R. Staben et al. Nature Chemistry
- Disulfide-Based Multifunctional Conjugates for Targeted Theranostic Drug Delivery
- (2015) Min Hee Lee et al. ACCOUNTS OF CHEMICAL RESEARCH
- Gold(i) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents
- (2015) Tatiyana V. Serebryanskaya et al. DALTON TRANSACTIONS
- Synthesis of Xanthohumol Analogues and Discovery of Potent Thioredoxin Reductase Inhibitor as Potential Anticancer Agent
- (2015) Baoxin Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Selenol Fluorescent Probes: Design, Synthesis, Structural Determinants, and Biological Applications
- (2015) Baoxin Zhang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Dual protection of hydroxytyrosol, an olive oil polyphenol, against oxidative damage in PC12 cells
- (2015) Shoujiao Peng et al. Food & Function
- An Activatable Theranostic for Targeted Cancer Therapy and Imaging
- (2014) Sankarprasad Bhuniya et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A furanyl acryl conjugated coumarin as an efficient inhibitor and a highly selective off–on fluorescent probe for covalent labelling of thioredoxin reductase
- (2014) Lei Huang et al. CHEMICAL COMMUNICATIONS
- Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer
- (2014) Lucas de Sousa Cavalcante et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Interaction of adenanthin with glutathione and thiol enzymes: Selectivity for thioredoxin reductase and inhibition of peroxiredoxin recycling
- (2014) Marjolein Soethoudt et al. FREE RADICAL BIOLOGY AND MEDICINE
- Evidence for Targeting Thioredoxin Reductases with Ferrocenyl Quinone Methides. A Possible Molecular Basis for the Antiproliferative Effect of Hydroxyferrocifens on Cancer Cells
- (2014) Anna Citta et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dithiaarsanes Induce Oxidative Stress-Mediated Apoptosis in HL-60 Cells by Selectively Targeting Thioredoxin Reductase
- (2014) Yaping Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development and Bioorthogonal Activation of Palladium-Labile Prodrugs of Gemcitabine
- (2014) Jason T. Weiss et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vivo and in Situ Tracking Cancer Chemotherapy by Highly Photostable NIR Fluorescent Theranostic Prodrug
- (2014) Xumeng Wu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- An Activatable Prodrug for the Treatment of Metastatic Tumors
- (2014) Eun-Joong Kim et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Identification of Michael Acceptor-Centric Pharmacophores with Substituents That Yield Strong Thioredoxin Reductase Inhibitory Character Correlated to Antiproliferative Activity
- (2013) Fei-Fei Gan et al. ANTIOXIDANTS & REDOX SIGNALING
- Highly Selective Off–On Fluorescent Probe for Imaging Thioredoxin Reductase in Living Cells
- (2013) Liangwei Zhang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Folate-Based Near-Infrared Fluorescent Theranostic Gemcitabine Delivery
- (2013) Zhigang Yang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Gemcitabine–Coumarin–Biotin Conjugates: A Target Specific Theranostic Anticancer Prodrug
- (2013) Sukhendu Maiti et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The Thioredoxin System as a Therapeutic Target in Human Health and Disease
- (2012) Dler Faieeq Darweesh Mahmood et al. ANTIOXIDANTS & REDOX SIGNALING
- Direct Fluorescence Monitoring of the Delivery and Cellular Uptake of a Cancer-Targeted RGD Peptide-Appended Naphthalimide Theragnostic Prodrug
- (2012) Min Hee Lee et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Small molecule inhibitors of mammalian thioredoxin reductase
- (2011) Wenqing Cai et al. FREE RADICAL BIOLOGY AND MEDICINE
- Structural and Kinetic Characterization of Human Deoxycytidine Kinase Variants Able To Phosphorylate 5-Substituted Deoxycytidine and Thymidine Analogues,
- (2010) Saugata Hazra et al. BIOCHEMISTRY
- Selenoproteins—What unique properties can arise with selenocysteine in place of cysteine?
- (2010) Elias S.J. Arnér EXPERIMENTAL CELL RESEARCH
- Selenoproteins
- (2008) Jun Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started